No.1
適時開示 適時開示
2026/09/14 19:21
事業の状況
Voluntary and Business Update Announcement Approval of Drug Clinical Trials for Systemic Lupus Erythematosus of Innovative Drug Highly Selective TYK2 Inhibitor CMS-D001
Voluntary and Business Update Announcement Approval of Drug Clinical Trials for Systemic Lupus Erythematosus of Innovative Drug Highly Selective TYK2 Inhibitor CMS-D001